C92 C90.0 C81 C85 C96.8
Conditions
Interventions
Group 1: Leukaemia, Lymphoma, Myeloproliferative neoplasm, Multiple myeloma, Histiocytosis and solid tumours.
Planned line of investigations: Influence of malignant cells in tumor microenvironment, m
Sponsors
Universitätsklinikum Schleswig-Holstein, Campus Lübeck
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Cancer patients providing consent
Exclusion criteria
Exclusion criteria: Patients not providing consent and minors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determine if the tissue surrounding tumour cells exhibits a higher mutation rate compared to non-infiltrated tissue | — |
Secondary
| Measure | Time frame |
|---|---|
| Exploring the factors underlying the heightened mutation rate in adjacent tissue, encompassing genetic, metabolic, and proteomic changes. Additionally, the correlation between mutation rates in the stroma and patients' prognosis and outcomes will be investigated. | — |
Countries
Germany
Contacts
Public ContactCyrus Khandanpour
Universitätsklinikum Schleswig-Holstein, Campus Lübeck
Outcome results
None listed